Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Phyllis J Goodman

Showing results (51-60 of 157) with videos related to

Pageof 16
Sort By:
Cancer Prevention Research (Philadelphia, Pa.)|February 28, 2020
Vitamin D Pathway and Other Related Polymorphisms and Risk of Prostate Cancer: Results from the Prostate Cancer Prevention TrialKathleen Torkko, Cathee Till, Catherine M Tangen, et al.
Cancer Prevention Research (Philadelphia, Pa.)|March 25, 2010
Serum oxidized protein and prostate cancer risk within the Prostate Cancer Prevention TrialAshraful Hoque, Christine B Ambrosone, Cathee Till, et al.
JAMA Oncology|November 7, 2024
Long-Term Adverse Effects and Complications After Prostate Cancer TreatmentJoseph M Unger, Cathee Till, Catherine M Tangen, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|October 13, 2006
Obesity, diabetes, and risk of prostate cancer: results from the prostate cancer prevention trialZhihong Gong, Marian L Neuhouser, Phyllis J Goodman, et al.
Molecular Carcinogenesis|January 11, 2018
Circadian genes and risk of prostate cancer in the prostate cancer prevention trialLisa W Chu, Cathee Till, Baiyu Yang, et al.
Cancer Causes & Control : CCC|November 1, 2014
Prospective study of human herpesvirus type 8 serostatus and prostate cancer risk in the placebo arm of the Prostate Cancer Prevention TrialSiobhan Sutcliffe, Cathee Till, Frank J Jenkins, et al.
The Prostate|April 21, 2015
Prostate stromal cell telomere shortening is associated with risk of prostate cancer in the placebo arm of the Prostate Cancer Prevention TrialChristopher M Heaphy, Gaurav Gaonkar, Sarah B Peskoe, et al.
Cancer Causes & Control : CCC|November 22, 2015
Serum androgens and prostate cancer risk: results from the placebo arm of the Prostate Cancer Prevention TrialJeannette M Schenk, Cathee Till, Ann W Hsing, et al.
The Journal of Urology|February 13, 2014
Statin drug use is not associated with prostate cancer risk in men who are regularly screenedElizabeth A Platz, Catherine M Tangen, Phyllis J Goodman, et al.
The Prostate|June 22, 2016
Peripheral Zone Inflammation Is Not Strongly Associated With Lower Urinary Tract Symptom Incidence and Progression in the Placebo Arm of the Prostate Cancer Prevention Trial Ibrahim Kulac, Berrak Gumuskaya, Charles G Drake, et al.
Pageof 16

Showing results (51-60 of 157) with videos related to

Sort By:
Pageof 16
Cancer Prevention Research (Philadelphia, Pa.)|February 28, 2020
Vitamin D Pathway and Other Related Polymorphisms and Risk of Prostate Cancer: Results from the Prostate Cancer Prevention TrialKathleen Torkko, Cathee Till, Catherine M Tangen, et al.
Cancer Prevention Research (Philadelphia, Pa.)|March 25, 2010
Serum oxidized protein and prostate cancer risk within the Prostate Cancer Prevention TrialAshraful Hoque, Christine B Ambrosone, Cathee Till, et al.
JAMA Oncology|November 7, 2024
Long-Term Adverse Effects and Complications After Prostate Cancer TreatmentJoseph M Unger, Cathee Till, Catherine M Tangen, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|October 13, 2006
Obesity, diabetes, and risk of prostate cancer: results from the prostate cancer prevention trialZhihong Gong, Marian L Neuhouser, Phyllis J Goodman, et al.
Molecular Carcinogenesis|January 11, 2018
Circadian genes and risk of prostate cancer in the prostate cancer prevention trialLisa W Chu, Cathee Till, Baiyu Yang, et al.
Cancer Causes & Control : CCC|November 1, 2014
Prospective study of human herpesvirus type 8 serostatus and prostate cancer risk in the placebo arm of the Prostate Cancer Prevention TrialSiobhan Sutcliffe, Cathee Till, Frank J Jenkins, et al.
The Prostate|April 21, 2015
Prostate stromal cell telomere shortening is associated with risk of prostate cancer in the placebo arm of the Prostate Cancer Prevention TrialChristopher M Heaphy, Gaurav Gaonkar, Sarah B Peskoe, et al.
Cancer Causes & Control : CCC|November 22, 2015
Serum androgens and prostate cancer risk: results from the placebo arm of the Prostate Cancer Prevention TrialJeannette M Schenk, Cathee Till, Ann W Hsing, et al.
The Journal of Urology|February 13, 2014
Statin drug use is not associated with prostate cancer risk in men who are regularly screenedElizabeth A Platz, Catherine M Tangen, Phyllis J Goodman, et al.
The Prostate|June 22, 2016
Peripheral Zone Inflammation Is Not Strongly Associated With Lower Urinary Tract Symptom Incidence and Progression in the Placebo Arm of the Prostate Cancer Prevention Trial Ibrahim Kulac, Berrak Gumuskaya, Charles G Drake, et al.
Pageof 16